Evidence map›Paper›PMID 32467660›Full record

ArticleTropical medicine and health2020

Evaluation of

Morteza Mousavi-Hasanzadeh, Hossein Sarmadian, Reza Ghasemikhah, Mojtaba Didehdar, Maryam Shahdoust, Mahshid Maleki, Mahdieh Taheri

Open access · goldAbstract read
In one paragraph

Article in Tropical medicine and health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Seroprevalence and Risk Factors Associated withJournal of parasitology research · 2022
    Article
  7. Comparisons ofArchives of Razi Institute · 2021
    Article
  8. Article
  9. Review
  10. Seroprevalence of Anti-Iranian journal of parasitology
    Article
  11. Seroprevalence and Risk Factors forIranian journal of parasitology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Morteza Mousavi-Hasanzadeh1Student Research Committee, Arak University of Medical Sciences, Arak, Iran.
Hossein Sarmadian2Department of Infectious Diseases, Arak University of Medical Sciences, Arak, Iran.
Reza Ghasemikhah3Departments of Parasitology and Mycology, Arak University of Medical Sciences, Arak, Iran.ORCID 0000-0002-9677-7484
Mojtaba Didehdar3Departments of Parasitology and Mycology, Arak University of Medical Sciences, Arak, Iran.
Maryam Shahdoust4Department of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
Mahshid Maleki5Department of Medical, Faculty of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran.
Mahdieh Taheri6Department of Medical, Faculty of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran.
Arak University of Medical Sciences · IRHamedan University of Medical Sciences · IRIran University of Medical Sciences · IRIsfahan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundToxoplasmosis is a parasitic infectious disease, and

methodsThis cross-sectional study was performed within 6 months on individuals who were referred to diagnostic laboratories in Markazi Province. The demographic and background information of the subjects were collected using a questionnaire. Three milliliters of blood samples was collected from the participants under sterile conditions. The sera were separated and evaluated for levels of anti-

resultsOut of 824 people from the general population of Markazi Province who were investigated in this study, 276 (33.5%) had anti-

conclusionThe mean prevalence of

Indexed as

General populationIgG anti-ToxoplasmaToxoplasma gondiiToxoplasmosis

Identifiers

PMID32467660
PMCPMC7236115
OpenAlexW3028185809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.